These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11703320)

  • 1. Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern.
    Rezvany MR; Jeddi-Tehrani M; Biberfeld P; Söderlund J; Mellstedt H; Osterborg A; Rabbani H
    Br J Haematol; 2001 Nov; 115(2):263-71. PubMed ID: 11703320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia.
    Rezvany MR; Jeddi-Tehrani M; Rabbani H; Lewin N; Avila-Cariño J; Osterborg A; Wigzell H; Mellstedt H
    Br J Haematol; 2000 Nov; 111(2):608-17. PubMed ID: 11122109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties.
    Carrasco CP; Rigden RC; Schaffner R; Gerber H; Neuhaus V; Inumaru S; Takamatsu H; Bertoni G; McCullough KC; Summerfield A
    Immunology; 2001 Oct; 104(2):175-84. PubMed ID: 11683958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha.
    Zheng Z; Takahashi M; Narita M; Toba K; Liu A; Furukawa T; Koike T; Aizawa Y
    J Hematother Stem Cell Res; 2000 Aug; 9(4):453-64. PubMed ID: 10982243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia].
    Wu CY; Zhang LS; Zhang YF; Chai Y; Yi LC; Song FX
    Ai Zheng; 2005 Apr; 24(4):425-31. PubMed ID: 15820064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypical and functional heterogeneity of dendritic cells generated from murine bone marrow cultured with different cytokine combinations: implications for anti-tumoral cell therapy.
    Masurier C; Pioche-Durieu C; Colombo BM; Lacave R; Lemoine FM; Klatzmann D; Guigon M
    Immunology; 1999 Apr; 96(4):569-77. PubMed ID: 10233743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia.
    Eisendle K; Lang A; Eibl B; Nachbaur D; Glassl H; Fiegl M; Thaler J; Gastl G
    Br J Haematol; 2003 Jan; 120(1):63-73. PubMed ID: 12492578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell-tumour hybrids in B-CLL.
    Kokhaei P; Rezvany MR; Virving L; Choudhury A; Rabbani H; Osterborg A; Mellstedt H
    Leukemia; 2003 May; 17(5):894-9. PubMed ID: 12750703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1.
    Lardon F; Snoeck HW; Berneman ZN; Van Tendeloo VF; Nijs G; Lenjou M; Henckaerts E; Boeckxtaens CJ; Vandenabeele P; Kestens LL; Van Bockstaele DR; Vanham GL
    Immunology; 1997 Aug; 91(4):553-9. PubMed ID: 9378494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturation of Peyer's patch dendritic cells in vitro upon stimulation via cytokines or CD40 triggering.
    Ruedl C; Hubele S
    Eur J Immunol; 1997 Jun; 27(6):1325-30. PubMed ID: 9209480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate.
    Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
    Clin Exp Immunol; 2001 Oct; 126(1):16-28. PubMed ID: 11678895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maturation of dendritic cells by recombinant human CD40L-trimer leads to a homogeneous cell population with enhanced surface marker expression and increased cytokine production.
    Würtzen PA; Nissen MH; Claesson MH
    Scand J Immunol; 2001 Jun; 53(6):579-87. PubMed ID: 11422906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.
    Pickl WF; Majdic O; Kohl P; Stöckl J; Riedl E; Scheinecker C; Bello-Fernandez C; Knapp W
    J Immunol; 1996 Nov; 157(9):3850-9. PubMed ID: 8892615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4 and CD40 ligation affect differently the differentiation, maturation, and function of human CD34+ cell-derived CD1a+CD14- and CD1a-CD14+ dendritic cell precursors in vitro.
    Canque B; Camus S; Yagello M; Gluckman JC
    J Leukoc Biol; 1998 Aug; 64(2):235-44. PubMed ID: 9715264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL).
    Rossmann ED; Lewin N; Jeddi-Tehrani M; Osterborg A; Mellstedt H
    Eur J Haematol; 2002 May; 68(5):299-306. PubMed ID: 12144536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells from chronic lymphocytic leukemia patients are normal regardless of Ig V gene mutation status.
    Messmer D; Telusma G; Wasil T; Messmer BT; Allen S; Rai KR; Chiorazzi N
    Mol Med; 2004; 10(7-12):96-103. PubMed ID: 16113842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukaemia.
    Vuillier F; Maloum K; Thomas EK; Jouanne C; Dighiero G; Scott-Algara D
    Br J Haematol; 2001 Dec; 115(4):831-44. PubMed ID: 11843817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-alpha disables dendritic cell precursors: dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation.
    Dauer M; Pohl K; Obermaier B; Meskendahl T; Röbe J; Schnurr M; Endres S; Eigler A
    Immunology; 2003 Sep; 110(1):38-47. PubMed ID: 12941139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions.
    Matera L; Galetto A; Geuna M; Vekemans K; Ricotti E; Contarini M; Moro F; Basso G
    Immunology; 2000 May; 100(1):29-36. PubMed ID: 10809956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.